Effects of Dihydrotestosterone on Bone Biochemical Markers in Sham and Oophorectomized Rats
- 1 September 1997
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 12 (9) , 1431-1437
- https://doi.org/10.1359/jbmr.1997.12.9.1431
Abstract
Evidence exists to suggest that androgens stimulate bone formation in the estrogen-deficient state, however the mechanism of action is unclear. The following study investigates the effect of dihydrotestosterone (DHT) on biochemical markers of bone turnover and calcium homeostasis in sham and oophorectomized (oophx) rats when either vehicle, 40, 80, or 160 mg/kg body weight (bw) DHT were administered at the time of operation or at 15 weeks postoperation. Serum alkaline phosphatase (ALP) increased following DHT administration in sham and oophx rats in all groups (mean ALP +/- SEM [U/l] week 8; sham vehicle, 40 +/- 7; sham 160 mg DHT/kg bw, 72 +/- 5; oophx vehicle, 60 +/- 6; oophx 160 mg DHT/kg bw, 88 +/- 11) (p < 0.001). In contrast, serum osteocalcin was significantly suppressed in oophx rats administered DHT 15 weeks following operation (mean osteocalcin +/- SEM [micrograms/l] week 8; oophx vehicle, 17.6 +/- 3.5; oophx 160 mg DHT/kg bw, 10.5 +/- 1) (p < 0.01). Urine deoxypyridinoline was significantly decreased when DHT was administered 15 weeks postoophorectomy (p < 0.001); however, urine hydroxyproline was not affected by DHT treatment in any group. Urine calcium was decreased by DHT treatment (mean Ca/Cr +/- SEM week 8; sham vehicle, 0.87 +/- 0.13; sham 160 mg DHT/kg bw, 0.24 +/- 0.08; oophx vehicle, 0.68 +/- 0.16; oophx 160 mg DHT/kg bw; 0.45 +/- 0.1) (p < 0.005) which was associated with an increase in the renal tubular reabsorption of calcium (p < 0.05). This study demonstrates the direct effects of DHT on both bone cell activities and the renal handling of calciumKeywords
This publication has 18 references indexed in Scilit:
- Effects of dihydrotestosterone alone and combined with estrogen on bone mineral density, bone growth, and formation rates in ovariectomized ratsBone, 1996
- Flutamide-mediated androgen blockade evokes osteopenia in the female ratJournal of Bone and Mineral Research, 1993
- Effects of oophorectomy on biochemical and bone variables in the ratBone and Mineral, 1992
- The ovariectomized rat model of postmenopausal bone lossBone and Mineral, 1991
- Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseasesEuropean Journal of Clinical Investigation, 1991
- Androgen treatment prevents loss of cancellous bone in the orchidectomized ratJournal of Bone and Mineral Research, 1991
- Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrixJournal of Cellular Physiology, 1990
- Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of actionMetabolism, 1983
- Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosisJournal of Clinical Investigation, 1972
- The determination of hydroxyproline in urine hydrolysatesClinica Chimica Acta; International Journal of Clinical Chemistry, 1970